MGM116041: An Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of Migalastat Hydrochloride Monotherapy in Subjects with Fabry Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date4/29/134/30/15

Funding

  • GlaxoSmithKline LLC (MGM116041)